Cargando…

Renal Biomarker and Angiostatic Mediator? Cystatin C as a Negative Regulator of Vascular Endothelial Cell Homeostasis and Angiogenesis

See Article by Li et al.

Detalles Bibliográficos
Autor principal:	Benndorf, Ralf A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404208/ https://www.ncbi.nlm.nih.gov/pubmed/30571391 http://dx.doi.org/10.1161/JAHA.118.010997

Ejemplares similares

Angiostatic vaccines, an underestimated approach of cancer therapy
por: Griffioen, Arjan W.
Publicado: (2014)

Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis
por: Sabatel, Céline, et al.
Publicado: (2010)

15-LOX metabolites and angiogenesis: angiostatic effect of 15(S)-HPETE involves induction of apoptosis in adipose endothelial cells
por: Soumya, Sasikumar J., et al.
Publicado: (2014)

Proteomic profiling of endorepellin angiostatic activity on human endothelial cells
por: Zoeller, Jason J, et al.
Publicado: (2008)

Cystatin C as a Promising Biomarker of Atherosclerotic Plaque
por: Sawada, Shojiro
Publicado: (2021)

The response of VEGF-stimulated endothelial cells to angiostatic molecules is substrate-dependent
por: Addison, Christina L, et al.
Publicado: (2005)

Angiostatic cues from the matrix: Endothelial cell autophagy meets hyaluronan biology
por: Chen, Carolyn G., et al.
Publicado: (2021)

Rac1, caveolin-1 and vascular endothelial growth factor -mediated liver sinusoidal endothelial cell angiogenesis
por: Braet, Filip
Publicado: (2009)

Anti-Vascular Endothelial Growth Factor Agents for Ocular Angiogenesis and Vascular Permeability
por: Kubota, Toshiaki, et al.
Publicado: (2012)

Serum Cystatin C as a Biomarker for Predicting Coronary Artery Disease in Diabetes
por: Oh, Jee-Young
Publicado: (2010)

Discrepant changes of urinary cystatin C and other urinary biomarkers in preterm neonates()
por: Filler, Guido, et al.
Publicado: (2021)

Regulation of endothelial homeostasis, vascular development and angiogenesis by the transcription factor ERG
por: Shah, Aarti V., et al.
Publicado: (2016)

Serum cystatin C and mild cognitive impairment: The mediating role of glucose homeostasis
por: Li, Kai, et al.
Publicado: (2023)

A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesis
por: Dorrell, Michael I., et al.
Publicado: (2021)

A Thromboxane A(2) Receptor-Driven COX-2–Dependent Feedback Loop That Affects Endothelial Homeostasis and Angiogenesis
por: Eckenstaler, Robert, et al.
Publicado: (2022)

Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion
por: Nowak-Sliwinska, Patrycja, et al.
Publicado: (2012)

Angiogenic and angiostatic factors present in the saliva of malaria patients
por: Lekpor, Cecilia Elorm, et al.
Publicado: (2022)

Oncofoetal insulin receptor isoform A marks the tumour endothelium; an underestimated pathway during tumour angiogenesis and angiostatic treatment
por: Nowak-Sliwinska, Patrycja, et al.
Publicado: (2018)

Negative Regulators of Angiogenesis, Ocular Vascular Homeostasis, and Pathogenesis and Treatment of Exudative AMD
por: Farnoodian, Mitra, et al.
Publicado: (2018)

Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization
por: Weiss, Andrea, et al.
Publicado: (2014)

Serum cystatin C is an early renal dysfunction biomarker in patients with hepatitis C virus
por: Assem, Nagwa Mohamed, et al.
Publicado: (2022)

Cystatin C: not just a marker of kidney function
por: Fernando, Sanduni, et al.
Publicado: (2020)

Angiostatic Factors in the Pulmonary Endarterectomy Material from Chronic Thromboembolic Pulmonary Hypertension Patients Cause Endothelial Dysfunction
por: Zabini, Diana, et al.
Publicado: (2012)

NF-κB: a new player in angiostatic therapy
por: Tabruyn, Sebastien P., et al.
Publicado: (2008)

Antitumor and Angiostatic Activities of the Antimicrobial Peptide Dermaseptin B2
por: van Zoggel, Hanneke, et al.
Publicado: (2012)

Rapid optimization of drug combinations for the optimal angiostatic treatment of cancer
por: Weiss, Andrea, et al.
Publicado: (2015)

Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers
por: Distler, Oliver, et al.
Publicado: (2002)

Improved Vascular Engraftment and Graft Function After Inhibition of the Angiostatic Factor Thrombospondin-1 in Mouse Pancreatic Islets
por: Olerud, Johan, et al.
Publicado: (2008)

Photoactivation of lysosomally sequestered sunitinib after angiostatic treatment causes vascular occlusion and enhances tumor growth inhibition
por: Nowak-Sliwinska, P, et al.
Publicado: (2015)

Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma
por: Guo, Shengjie, et al.
Publicado: (2017)

Cystatin C as a Candidate Biomarker of Cardiovascular Outcomes: Too Near, but too Far from Reality
por: de Carvalho, Luiz Sérgio F., et al.
Publicado: (2018)

Adenoviral gene transfer of angiostatic ATF-BPTI inhibits tumour growth
por: Lefesvre, Pierre, et al.
Publicado: (2002)

The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future
por: Hamming, Lisanne C., et al.
Publicado: (2017)

Active RhoA Exerts an Inhibitory Effect on the Homeostasis and Angiogenic Capacity of Human Endothelial Cells
por: Hauke, Michael, et al.
Publicado: (2022)

Angiostatic actions of capsicodendrin through selective inhibition of VEGFR2-mediated AKT signaling and disregulated autophagy
por: Pan, Christopher C., et al.
Publicado: (2016)

Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer
por: Gashenko, Elena A., et al.
Publicado: (2013)

Cystatin C in pregnant women is not a simple kidney filtration marker
por: Lee, Hajeong
Publicado: (2018)

Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy
por: Royakkers, Annick A. N. M., et al.
Publicado: (2010)

Detection of Cystatin C biomarker for clinical measurement of renal disease by developed ELISA diagnostic kits
por: Jiang, Renren, et al.
Publicado: (2014)

Cystatin-C as a Marker for Renal Impairment in Preeclampsia
por: Niraula, Apeksha, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2vq7r4ib8vnv7thpduh1nibqui